We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NEW YORK, June 5 /PRNewswire/ -- The Stilwell Group announced today that it is continuing to solicit proxies to vote for its three nominees for director at the June 22, 2006 annual stockholders...
RNS Number:1480U Skyepharma PLC 13 January 2004 For Immediate Release: 13 January, 2004 SkyePharma and Critical Therapeutics to develop controlled release formulation for treatment...
RNS Number:0914U Skyepharma PLC 12 January 2004 For Immediate Release 12 January, 2004 SkyePharma PLC Press Announcement SkyePharma Welcomes Canadian Approval of Paxil...
RNS Number:0064U Skyepharma PLC 08 January 2004 Immediate Release 8 January 2004 SkyePharma PLC ("the Company") Notification of Major Interest in Shares In accordance with...
RNS Number:0065U Skyepharma PLC 08 January 2004 Immediate Release 8 January 2004 SkyePharma PLC ("the Company") Notification of Major Interest in Shares In accordance with...
RNS Number:8371T Skyepharma PLC 05 January 2004 For Immediate Release 5 January, 2004 GLAXOSMITHKLINE LICENSES SKYEPHARMA FORMULATION TECHNOLOGY FOR RESPIRATORY DRUGS LONDON...
RNS Number:8370T Skyepharma PLC 05 January 2004 For Immediate Release 5 January, 2004 SKYEPHARMA PROVIDES END-2003 TRADING UPDATE LONDON, UK, 5 January 2004-- SkyePharma PLC...
RNS Number:7583T Skyepharma PLC 31 December 2003 For Immediate Release 31 December 2003 SkyePharma PLC ("the Company") As a result of transactions on 31 December 2003 by the SkyePharma...
RNS Number:5149T Skyepharma PLC 19 December 2003 For Immediate Release 19 December, 2003 SkyePharma PLC SKYEPHARMA'S FOUNDER AND CHAIRMAN TO STEP DOWN TO NON-EXECUTIVE ROLE...
RNS Number:4829T Skyepharma PLC 19 December 2003 For Immediate Release 19 December, 2003 SkyePharma PLC NEW STUDY SHOWS PATIENTS TREATED WITH PAXIL(R) CR FOR DEPRESSION ARE LESS...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions